DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)

Clinical trial NCT00224081 · COMPLETED

Trial details

NCT number: NCT00224081
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Anemia, Iron-Deficiency Kidney Failure, Chronic Hemodialysis

Start date: 2004-09-01
Primary completion: 2006-05-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.